Norway advises caution in use of Pfizer vaccine for the most frail | Inquirer News
Close  

Norway advises caution in use of Pfizer vaccine for the most frail

/ 11:03 PM January 18, 2021
Pfizer COVID-19 vaccine

A vial of Pfizer-BioNTech COVID-19 vaccine is pictured at the hospital in Le Mans, as part of the coronavirus disease (COVID-19) vaccination campaign in France, Jan. 14, 2021. (Photo by STEPHANE MAHE / Reuters)

FRANKFURT — Norway has changed its policy on the use of Pfizer and BioNTech’s COVID-19 vaccine to consider excluding the terminally ill, following reports of deaths in highly frail recipients after the inoculation was given, BioNTech said on Monday.

“Norwegian Health Authorities have now changed (their) recommendation in relation to vaccination of the terminally ill (Clinical Frailty Scale 8 or higher),” BioNTech.

ADVERTISEMENT

The Clinical Frailty Scale, a widely used system of classification in elderly care, defines degree 8 patients as approaching end of life and typically unable to “recover even from a minor illness”.

The Norwegian Medicines Agency said in a statement posted on Friday and updated on Monday that “common adverse reactions may have contributed to a severe course in elderly people who are frail”.

FEATURED STORIES

As of Jan. 14, 23 reports of suspected deaths have been submitted to the Norwegian health registry, it said.

“An evaluation should be carried for each individual patient as to whether the benefits of vaccination outweigh the risks of eventual side effects,” the Norwegian agency said.

In Norway, an average of 400 people die each week in nursing homes and long-term care facilities, the medicines agency said.

Germany’s health minister Jens Spahn said at a news briefing on Monday that the country’s vaccine regulator saw no need to revise guidelines and that it was in contact with their Norwegian counterparts.

The safety of vaccines is garnering global public attention after drugmakers developed the shots at breakneck speed to curb a pandemic that has killed more than 2 million people.

U.S. and European vaccine developers have pledged to uphold the scientific standards their immunizations will be held against in the race to contain the virus.

Stephen Evans, a professor of pharmacoepidemiology at the London School of Hygiene & Tropical Medicine, said there was no evidence so far of a causal link between the deaths of vulnerable patients in Norway and vaccination.

ADVERTISEMENT

“We do not yet know, but it would seem that the observed number of deaths is not notably above the numbers expected, but this will need to be examined continually in all countries where it can be done,” he said.

RELATED STORY

Pfizer’s EUA stays as FDA awaits report on Norway deaths — DOH

[atm]

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: BioNTech, coronavirus pandemic, Norway COVID-19 vaccine policy, Pfizer COVID-19 vaccine
For feedback, complaints, or inquiries, contact us.


© Copyright 1997-2021 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.